Catalent Inc. (CTLT) - Insider Holders & Insider Ownership

List of insiders holdings for Catalent Inc.:

Shares directly owned by the insider.
Shares indirectly owned by the insider.
Total shares owned by the insider (sum of shares directly and indirectly owned).
Total market value if available.
Shares are not adjusted for stock split.

"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

#	Insider Holder Name	Report Date Time	Shares Owned Directly Indirectly	Total Shares Owned	Filing
1	Zippelius Peter Director	2022-10-31 17:46:24	11,979 4,330,462	4,342,441	Form 4
2	Chiminski John R Executive Chair	2022-08-26 20:16:30	229,888 0	229,888	Form 4
3	WALSH MATTHEW M EVP & Chief Financial Officer	2017-08-28 12:29:43	103,703 0	103,703	Form 4
4	Joseph Wetteny SVP & Chief Financial Officer	2021-02-18 09:56:20	79,227 0	79,227	Form 4
5	Johnson Sharon See Remarks	2017-04-27 11:02:19	77,645 0	77,645	Form 4
6	Fasman Steven L EVP & Chief Admin Officer	2023-12-12 19:11:23	75,423 0	75,423	Form 4/A
7	Leonard Stephen See Remarks	2016-07-28 19:21:12	73,140 0	73,140	Form 4
8	Arnold Jonathan SVP, CCO & Div. Head BioP Del.	2023-12-12 18:58:20	57,573 0	57,573	Form 4/A
9	Kurt Nielsen See Remarks	2015-02-19 19:28:35	57,156 0	57,156	Form 4/A
10	Dolan Christine SVP - Product Development	2017-08-31 10:41:26	53,736 0	53,736	Form 4
11	Miyamoto Lance SVP, Human Resources	2019-03-11 19:31:14	46,799 0	46,799	Form 4
12	Downie William SVP, Global Sales & Marketing	2019-02-20 15:48:52	46,662 0	46,662	Form 4
13	BUZY PETER L President, Gene Therapy	2020-04-13 12:12:26	45,950 0	45,950	Form 4
14	Littlejohns Barry President, Biologics & SDD	2019-08-26 15:49:32	45,882 0	45,882	Form 4
15	Pravda Ricardo Chief Transformation Officer	2023-12-12 19:21:40	30,982 0	30,982	Form 4/A
16	Balachandran Madhavan Director	2023-10-31 17:07:40	27,441 0	27,441	Form 4
17	Grippo Michael J SVP, Strategy & Corp. Dev.	2023-12-12 19:05:25	25,229 0	25,229	Form 4/A
18	Flynn Karen Director	2023-10-31 17:00:54	24,339 0	24,339	Form 4
19	Crane Rosemary A Director	2023-10-31 17:02:08	23,873 0	23,873	Form 4
20	QUELLA JAMES Director	2017-08-28 11:31:48	20,641 0	20,641	Form 4
21	Castellano Thomas P SVP, Chief Financial Officer	2022-08-26 20:16:03	20,099 0	20,099	Form 4
22	Kreuzburg Christa Director	2024-01-29 16:09:05	18,283 0	18,283	Form 4
23	Schmidt Kay A SVP, Enterprise Functions	2022-08-26 20:23:59	17,388 0	17,388	Form 4
24	BOOTH MELVIN D Director	2016-08-26 14:56:50	16,665 0	16,665	Form 4
25	Roehrhoff Uwe Director	2017-11-22 16:25:28	16,489 0	16,489	Form 4
26	Houlton Scott See Remarks	2015-09-04 17:39:27	16,380 0	16,380	Form 4
27	Zayas Ricardo SVP, Operations, Biologics NA	2023-08-03 17:17:23	16,101 0	16,101	Form 4
28	Boerman Manja Pres. BioModalities Division	2023-05-03 19:00:37	14,414 0	14,414	Form 4
29	HEGWOOD PAUL W JR President, CSS	2019-08-26 15:48:26	11,848 0	11,848	Form 4
30	Lickfold Charles SVP, CIO	2023-12-12 19:19:54	11,719 0	11,719	Form 4/A
31	Hunt Patricia Pres. Consumer Health Div	2023-12-12 19:17:51	11,501 0	11,501	Form 4/A
32	Santiago Karen Murphy VP & Chief Accounting Officer	2023-08-03 17:21:21	9,979 0	9,979	Form 4
33	Carletti Lorenzo SVP Global Ops Ph & Cons Hlth	2023-12-12 19:09:14	9,178 0	9,178	Form 4/A
34	Hawkeswood Thomas W Pres. Pharma Prod Delivery Div	2023-12-12 19:16:02	7,827 0	7,827	Form 4/A
35	Riley Michael A. Pres. Bio Product Delivery Div	2022-08-30 14:38:01	6,592 0	6,592	Form 4
36	Gargiulo Mario SVP, Ops, Biologics Europe	2023-05-03 18:58:00	5,676 0	5,676	Form 4
37	Whitlow Ricci S President, CSS	2022-01-24 16:42:46	2,923 0	2,923	Form 4
38	Ryan Michelle R Director	2024-12-18 13:18:04	0 0	0	Form 4
39	DAMELIO FRANK A Director	2024-12-18 13:01:55	0 0	0	Form 4
40	Okey Stephanie Director	2024-12-18 13:08:55	0 0	0	Form 4
41	MOREL DONALD E JR Director	2024-12-18 13:06:47	0 0	0	Form 4
42	LUCIER GREGORY T Director	2024-12-18 13:04:16	0 0	0	Form 4
43	Gennadios Aristippos Group Pres. Pharma & Consumer	2024-12-18 14:10:11	0 0	0	Form 4
44	STAHL JACK L Director	2024-12-18 13:20:34	0 0	0	Form 4
45	Ferraro Joseph Anthony SVP, General Counsel, CCO	2024-12-18 13:56:18	0 0	0	Form 4
46	Gunther Scott SVP, Quality & Reg. Affairs	2024-12-18 14:00:41	0 0	0	Form 4
47	Hatzfeld Michael Chief Accounting Officer	2024-12-18 14:05:24	0 0	0	Form 4
48	McErlane David Group President, Biologics	2024-12-18 14:07:42	0 0	0	Form 4
49	McEvoy Bruce Director	2014-07-31 20:19:30	0 0	0	Form 3
50	CLASSON ROLF A Director	2024-12-18 12:59:21	0 0	0	Form 4
51	CARROLL J MARTIN Director	2024-12-18 12:57:08	0 0	0	Form 4
52	Barg Steven Director	2024-12-18 12:55:33	0 0	0	Form 4
53	Barber Michael J Director	2024-12-18 12:52:22	0 0	0	Form 4
54	Maselli Alessandro President & CEO	2024-12-18 11:13:00	0 0	0	Form 4
55	Hopson Ricky Pres. BioProduct Delivery, CoS	2024-12-18 11:12:48	0 0	0	Form 4
56	Masanovich Matti SVP, Chief Financial Officer	2024-12-18 11:12:23	0 0	0	Form 4
57	GREISCH JOHN J Executive Chair	2024-12-18 11:12:08	0 0	0	Form 4
58	Evoli Lisa SVP, Chief HR Officer	2024-12-18 11:11:39	0 0	0	Form 4
59	Blackstone Management Associates V L.L.C. Blackstone Healthcare Partners L.L.C. BLACKSTONE CAPITAL PARTNERS V L P BMA V L.L.C. Blackstone Holdings III L.P. Blackstone Holdings III GP L.P. Blackstone Holdings III GP Management L.L.C. Blackstone Group L.P. Blackstone Group Management L.L.C. SCHWARZMAN STEPHEN A 10% Owner	2017-02-14 14:25:56	0 0	0	Form 13G
60	Chu Chinh Director	2014-07-31 20:29:59	0 0	0	Form 3